CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women

AIDS Education and Prevention

Volumn 21, Issue SUPPL. 3, 2009, Pages 81-93

  Feldman, David N ^a,i   Feldman, Joseph G ^b   Greenblatt, Ruth ^c   Anastos, Kathryn ^d   Pearce, Leigh ^e   Cohen, Mardge ^f   Gange, Stephen ^g   Leanza, Suzanne ^h   Burk, Robbie ^h  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LINCOLN MEDICAL AND MENTAL HEALTH CENTER   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f Jr Hospital of Cook County   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; CYTOCHROME P450 1A1; CYTOCHROME P450 2A6; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; DIOXIN; GLUTATHIONE TRANSFERASE; POLYCYCLIC AROMATIC HYDROCARBON; TOBACCO SMOKE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; CD4 LYMPHOCYTE COUNT; CIGARETTE SMOKING; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DNA ADDUCT; ENVIRONMENTAL FACTOR; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C; HEREDITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; OXIDATION; SMOKING CESSATION; TREATMENT RESPONSE; VIROTHERAPY; VIRUS LOAD; VIRUS REPLICATION; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE COURSE; FOLLOW UP; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; METABOLISM; MULTICENTER STUDY; PATHOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; TREATMENT OUTCOME;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CYTOCHROME P-450 CYP1A1; DISEASE PROGRESSION; DNA ADDUCTS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; GENOTYPE; GLUTATHIONE TRANSFERASE; HIV INFECTIONS; HIV-1; HUMANS; KAPLAN-MEIERS ESTIMATE; LONGITUDINAL STUDIES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; PROPORTIONAL HAZARDS MODELS; SMOKING; TREATMENT OUTCOME; VIRAL LOAD; VIRUS REPLICATION;

EID: 67650179187     PISSN: 08999546     EISSN: None     Source Type: Journal    
DOI: 10.1521/aeap.2009.21.3_supp.81     Document Type: Conference Paper

References (28)

1. Barkan, S., Melnick, S., Preston-Martin, S., Weber, K., Kalish, L., Miotti, P., et al. (1998). The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology, 9, 117-125
2. Calvelli, T., Denny, T., Paxton, H., Gelman, R., & Kagan, J. (1993). Guidelines for flow cytometric immunophenotyping. Cytometry, 14, 702-715.
3. Centers for Disease Control and Prevention. (1992). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report, 41, 1-19.
4. Cohen, M. H., French, A. L., Benning, L., Kovacs, A., Anastos, K., Young, M., et al. (2002). Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. American Journal of Medicine, 113, 91-98. (Pubitemid 34804744)
5. Cook, J., Cohen, M. H., Grey, D., Kirstein, L., Burke, J., Anastos, K., et al. (2002). Use of highly active antiretroviral in a cohort of HIV-seropositive therapy women. American Journal of Public Health, 92, 82-87. (Pubitemid 36018895)
6. Feldman, J. G., Minkoff, H., Schneider, M. F., Gange, S. J., Cohen, M., Watts, D. H., et al. (2006). Impact of cigarette smoking on HIV prognosis among women in the HAART era-a report from the Women's Interagency HIV Study (WIHS). American Journal of Public Health, 96, 1060-1065. (Pubitemid 43825275)
7. Hamada, G., Sugimura, H., Suzuki, I., Nagura, K., Klyokawa, E., Iwase, T., et al. (1995). The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro. Cancer, Epidemiology Biomarkers and Prevention, 4(1), 63-67.
8. Hayashi, T., Ueno, Y., & Okamoto, T. (1993). Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. Journal of Biological Chemistry, 268(15), 11380-11388. (Pubitemid 23162336)
9. Hessol, N. A., Schneider, M., Greenblatt, R. M., Bacon, M., Barranday, Y., Holman, S., et al. (2001). Retention of women enrolled in a prospective study of human immunodeficiency virus infection: Impact of race, unstable housing, and use of human immunodeficiency virus therapy. American Journal of Epidemiology, 154, 563-573. (Pubitemid 32867956)
10. Keshava, C., Divi, R. L., Whipkey, D. L., Frye, B. L., McCanlies, E., Kuo, M., et al. (2005). Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene. Cancer Letters, 221, 213-224. (Pubitemid 40460408)
11. Kirstein, L. M., Greenblatt, R. M., Anastos, K., Levine, A., French, A. L., Minkoff, H., et al. (2002). Women's Interagency HIV Study Collaborative Research Group. Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study. Journal of Acquired Immune Deficiency Syndrome, 29, 495-503.
12. Landi, M. T., Bertazzi, P. A., Shields, P. G., Clark, G., Lucier, G. W., Garte, S.J., et al. (1994). Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics, 4, 242-246. (Pubitemid 24337432)
13. Li, Y., Millikan, R. C., Bell, D. A., Cui, L., Tse, C. K., Newman, B., et al. (2004). Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African- American and white women. [Epub] Breast Cancer Research, 6(4), R460-473.
14. Liu, S., Park, J. Y., Schantz, S. P., Stern, J. C., & Lazarus, P. (2001). Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral Oncology, 37(5), 437-445. (Pubitemid 32480281)
15. Mooney, L., Bell, D., Santella, R., Van Bennekum, A., Ottman, R., Paik, M., et al. (1997). Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis, 18(3), 503-509. (Pubitemid 28132487)
16. Ohata, H., Tetsuka, T., Hayashi, H., Onozaki, K., & Okamoto, T. (2003). 3-methylcholanthrene activates human immunodeficiency virus-1 replication via aryl hydrocarbon receptor. Microbiology and Immunology, 47(5), 363-370. (Pubitemid 36604622)
17. Okamoto, T., Benter, T., Josephs, S.F., Sadaie, M. R., & Wong-Staal, F. (1990). Transcriptional activation from the long-terminal repeat of human immunodeficiency virus in vitro. Virology, 177(2), 606-614. (Pubitemid 20235182)
18. Paschke, T., Riefler, M., Schuler-Metz, A., Wolz, L., Scherer, G., McBride, C. M., et al. (2001). Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method. Toxicology, 168(3), 259-268. (Pubitemid 33001451)
19. Pokrovsky, C., Cherykh, A., Yastrebova, O. N., & Tsyrlov, I. B. (1991). 2,3,7,8-Tetrachlorodibenzo- P-dioxin as a possible activator of HIV infection. Biochemical and Biophysical Research Communications, 179(1), 46-51.
20. Sellers, E. M. (1998). Pharmacogenetics and ethnoracial differences in smoking. Journal of the American Medical Association, 1280, 179-180.
21. Sepkowitz, K . (2001). AIDS-the first 20 years. New England Journal of Medicine, 344, 764-790.
22. Sobti, R. C., Sharma, S., Joshi, A., Jindal, S. K., & Janmeja, A. (2004). Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Molecular and Cellular Biochemistry, 266, 1-9. (Pubitemid 39562301)
23. Tefre, T., Ryberg, D., Haugen, A., Nebert, D.W., Skaug, V., Brogger, A., et al. (1991). Human CYP1A1 gene: Cosegregation of the enzyme inducibility phenotype and an RFLP. American Journal of Human Genetics, 48, 720-725. (Pubitemid 21891616)
24. Teixeira, J. P., Gaspar, J., Martinho, G., Silva, S., Rodrigues, S., Mayan, O., et al. (2002). Aromatic DNA adduct levels in coke oven workers: Correlation with polymorphisms in genes GSTP1, GSTM1, GSTT1 and CYP1A1. Mutation Research, 517(1-2), 147-155. (Pubitemid 34597014)
25. Wacholder, S., Chanock, S., Garcia-Glosas, M., El ghormli, L., & Rothman, N. (2004). Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. Journal of the National Cancer Institute , 96, 434-442.
26. Wilson, T. E., Barrón, Y., Cohen, M., Richardson, J., Greenblatt, R., Sacks, H. S., et al. (2002). Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clinical Infectious Diseases, 34, 529-534. (Pubitemid 34112276)
27. Yao, Y., Hoffer, A., Chang, C., & Puga, A. (1995). Dioxin activates HIV-1 gene expression by an oxidative stress pathway requiring a functional cytochrome P450 CYP1A1 enzyme. Environmental Health Perspectives, 103(4), 366-371.
28. Zackrisson, A. L., & Lindblom, B. (2003). Identification of CYP2D6 alleles by single nucleotide polymorphism analysis using pyrosequencing. European Journal of Clinical Pharmacology, 59(7), 521-526. (Pubitemid 37368904)